| |
| Issue |
Title |
| |
| No 10 (2025) |
Clinical case of therapy for BRCA1-associated metastatic pancreatic cancer |
Abstract
PDF (Rus)
|
|
A. Yu. Popov, T. P. Baitman, A. D. Simonov, , P. V. Markov, D. S. Gorin, A. A. Gritskevich, E. V. Kondratyev, D. V. Kalinin, N. V. Zhukov |
| |
| No 10 (2025) |
Hepatocellular carcinoma of non-viral etiology: From theory to real practice |
Abstract
PDF (Rus)
|
|
V. V. Petkau, N. E. Krasilnikova, E. N. Bessonova, A. A. Tarkhanov |
| |
| No 10 (2025) |
Rechallenge with BRAF and MEK inhibitors in the treatment of metastatic melanoma: A case report with a mini-review |
Abstract
PDF (Rus)
|
|
I. V. Samoylenko, A. R. Zaretsky, E. V. Prozorenko, L. V. Demidov |
| |
| No 21 (2024) |
NTRK translocation: from general to specific |
Abstract
PDF (Rus)
|
|
M. V. Soloveva, K. K. Laktionov, K. A. Sarantseva, M. G. Gordiev |
| |
| No 21 (2024) |
Efficacy and safety of lorlatinib as first-line treatment for advanced ALK-mutated non-small cell lung cancer: A clinical case study |
Abstract
PDF (Rus)
|
|
А. L. Kornietskaya, S. F. Evdokimova, L. V. Bolotina, E. O. Rodionov, A. A. Fedenko |
| |
| No 21 (2024) |
The role of cetuximab in treatment of squamous cell carcinoma of the head and neck |
Abstract
PDF (Rus)
|
|
I. A. Koroleva, M. V. Kopp |
| |
| No 21 (2024) |
Palbociclib in real clinical practice: Results of a single-center observational study |
Abstract
PDF (Rus)
|
|
A. V. Sultanbaev, I. V. Kolyadina, A. F. Nasretdinov, K. V. Menshikov, V. E. Askarov, Sh. I. Musin, K. T. Akhmetgareeva, N. I. Sultanbaeva, V. M. Zabelin, R. T. Ayupov, A. A. Izmailov |
| |
| No 10 (2024) |
Expanding the treatment options for HER2-low metastatic breast cancer: Experience with trastuzumab deruxtecan in aggressive luminal HER2-low breast cancer |
Abstract
PDF (Rus)
|
|
E. V. Lubennikova, I. P. Ganshina, M. Sh. Manukyan, I. E. Tyurin, E. V. Artamonova |
| |
| No 10 (2024) |
Evolution of therapy for ALK-positive lung carcinomas: Application of third-generation ALK inhibitors in real clinical practice |
Abstract
PDF (Rus)
|
|
A. F. Nasretdinov, A. V. Sultanbaev, Sh. I. Musin, K. V. Menshikov, R. T. Ayupov, A. A. Izmailov, G. A. Serebrennikov, V. E. Askarov, D. V. Feoktistov |
| |
| No 10 (2024) |
New treatment options for HER2-positive metastatic breast cancer with leptomeningeal metastases |
Abstract
PDF (Rus)
|
|
A. Yu. Goryainova, S. V. Sharov, O. I. Kirsanova, O. A. Goncharova, R. A. Murashko |
| |
| No 10 (2024) |
Ceritinib as a long-term disease control: Clinical observation |
Abstract
PDF (Rus)
|
|
E. V. Reutova, K. K. Laktionov, M. A. Ardzinba |
| |
| No 10 (2024) |
The therapeutic features of EGFR L858R exon 21 mutation in non-small cell lung cancer |
Abstract
PDF (Rus)
|
|
M. O. Mandrina, T. D. Barbolina, L. Yu. Vladimirova, A. E. Storozhakova, K. K. Laktionov |
| |
| No 22 (2023) |
Place of tyrosine kinase inhibitors in the first line of treatment of hepatocellular carcinoma |
Abstract
PDF (Rus)
|
|
A. V. Sergeeva, M. Sh. Manukyan, A. N. Polyakov, I. S. Bazin |
| |
| No 22 (2023) |
Entrectinib in the treatment of ROS1-positive lung cancer |
Abstract
PDF (Rus)
|
|
E. V. Reutova, K. K. Laktionov |
| |
| No 22 (2023) |
First-line treatment option for patients with ALK-positive metastatic NSCLC |
Abstract
PDF (Rus)
|
|
A. L. Kornietskaya, L. V. Bolotina, S. F. Evdokimova, N. S. Prizova, Yu. B. Karagodina, V. V. Savchina, A. A. Fedenko |
| |
| No 11 (2023) |
Targeted therapy for МЕТ-positive non-small cell lung cancer |
Abstract
PDF (Rus)
|
|
K. K. Laktionov, E. V. Reutova |
| |
| No 11 (2023) |
Safety profile of lorlatinib: correction of adverse events |
Abstract
PDF (Rus)
|
|
E. V. Reutova, K. K. Laktionov, E. Yu. Antonova, J. K. Avakyants, G. A. Tkachenko |
| |
| No 11 (2023) |
Trastuzumab deruxtecan heralds new era in the treatment of metastatic breast cancer |
Abstract
PDF (Rus)
|
|
E. V. Lubennikova, E. V. Artamonova |
| |
| No 22 (2022) |
Therapy of BRCA-associated metastatic breast cancer. Efficacy and safety of talazoparib in the real-world clinical practice |
Abstract
PDF (Rus)
|
|
E. V. Lubennikova, A. L. Kornietskaya, N. S. Dorofeeva, E. I. Rossokha, E. V. Markarova, I. V. Yudina, I. Y. Bazaeva, L. V. Bolotina, T. I. Deshkina, Ya. A. Zhulikov, E. V. Stasenko, T. V. Ustinova, A. S. Tsareva, E. V. Artamonova |
| |
| No 22 (2022) |
Real clinical practice patterns of palbociclib usage in Russian Federation |
Abstract
PDF (Rus)
|
|
M. A. Frolova, M. В. Stenina |
| |
| No 22 (2022) |
Role of ribociclib in treatment of luminal Her-2-negative mBC with CNS metastases |
Abstract
PDF (Rus)
|
|
K. S. Grechukhina, K. A. Vorontsova, D. A. Filonenko, P. S. Tyutyunnik, V. V. Shchadrova, V. V. Glebovskaya, L. G. Zhukova |
| |
| No 22 (2022) |
Lorlatinib: new therapeutic options for ALK-positive patients |
Abstract
PDF (Rus)
|
|
E. V. Reutova |
| |
| No 9 (2022) |
Resolution on the results of Advisory Board “Searching the effective methods of testing and treating patients with NSCLC caused by NTRK gene fusions“ |
Abstract
PDF (Rus)
|
|
E. V. Artamonova, V. V. Breder, L. Yu. Vladimirova, I. A. Demidova, E. N. Imyanitov, К. К. Laktionov, M. P. Matrosova, S. V. Orlov, E. О. Rodionov, D. D. Sakaeva, M. I. Sekacheva, A. V. Smolin, N. V. Fadeeva, M. L. Filipenko |
| |
| No 9 (2022) |
Alpelisib therapy: from theory to practice |
Abstract
PDF (Rus)
|
|
E. V. Lubennikova, T. A. Titova, I. P. Ganshina |
| |
| No 9 (2022) |
Evolution of the CDK4/6 inhibitor abemaciclib: from palliative to adjuvant therapy. Clinical experience with abemaciclib in patients with hormone-receptor-positive, HER2-negative breast cancer |
Abstract
PDF (Rus)
|
|
A. Yu. Goryainova, A. I. Stukan, R. A. Murashko, S. V. Sharov, E. V. Lymar |
| |
| No 9 (2021) |
Erlotinib: How to increase the duration of effective use of tyrosine kinase inhibitors in non-small cell lung cancer with EGFR mutation |
Abstract
PDF (Rus)
|
|
E. I. Borisova, S. L. Gutorov |
| |
| No 9 (2021) |
Experience in treating BRCA-associated breast cancer. The BRCA-history of a family |
Abstract
PDF (Rus)
|
|
A. V. Sultanbaev, K. V. Menshikov, A. F. Nasretdinov, A. A. Izmailov, S. I. Musin, I. A. Menshikova, A. V. Chashchin, N. I. Sultanbaeva |
| |
| 1 - 27 of 27 Items |
|
